Trending

Genmab

J&J rumoured to be sizing up $12bn Genmab acquisition

J&J rumoured to be sizing up $12bn Genmab acquisition

Speculation mounts that J&J will bid for R&D partner

X

J&J rumoured to be sizing up $12bn Genmab acquisition

https://pharmaphorum.com/news/jj-buy-danish-biotech-genmab/

Novartis’ Arzerra gains CLL approval

Novartis’ Arzerra gains CLL approval

Development partner Genmab says drug approved in relapsed disease.

X

Novartis’ Arzerra gains CLL approval

https://pharmaphorum.com/news/novartis-arzerra-gets-new-us-cll-use/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com